Market revenue in 2022 | USD 20.8 million |
Market revenue in 2030 | USD 38.1 million |
Growth rate | 7.8% (CAGR from 2022 to 2030) |
Largest segment | Extracorporeal co2 machines |
Fastest growing segment | Extracorporeal CO2 machines |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Extracorporeal CO2 machines, Disposables, Other Products |
Key market players worldwide | Medtronic PLC, Getinge AB ADR, Fresenius Medical Care AG, LivaNova PLC, Aferetica, Estor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to extracorporeal co2 removal devices market will help companies and investors design strategic landscapes.
Extracorporeal co2 machines was the largest segment with a revenue share of 52.88% in 2022. Horizon Databook has segmented the Europe extracorporeal co2 removal devices market based on extracorporeal co2 machines, disposables, other products covering the revenue growth of each sub-segment from 2017 to 2030.
Europe is one of the most developed regions in the world. Increasing public & private investment in R&D are some of the significant factors contributing to the growth of this region. Rising demand for healthcare devices coupled with increasing prevalence of chronic diseases, such as respiratory failure and cardiopulmonary diseases, in the region are some major drivers anticipated to augment regional growth. Increasing demand for advanced technologies and rising health awareness are some of the key factors that are expected to boost market growth.
Growing healthcare expenditure in this region is expected to boost technological advancements in the healthcare industry and thus can be one of the factors responsible for driving the ECCO2R removal devices market. In addition, favorable reimbursement policies, increase in government investments in long-term healthcare plans, and growing healthcare research infrastructure are also expected to boost adoption of extracorporeal CO2 removal devices.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe extracorporeal co2 removal devices market, including forecasts for subscribers. This continent databook contains high-level insights into Europe extracorporeal co2 removal devices market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account